Safety of Intravenous Application of Second-Generation Ultrasound Contrast Agent in Children: Prospective Analysis
- 17 February 2015
- journal article
- Published by Elsevier BV in Japanese Journal of Clinical Oncology
- Vol. 41 (4), 1095-1099
- https://doi.org/10.1016/j.ultrasmedbio.2014.11.003
Abstract
No abstract availableKeywords
Funding Information
- National Science Centre (DEC-2012/05/B/NZ5/01554)
This publication has 14 references indexed in Scilit:
- Safety of contrast-enhanced ultrasound in children for non-cardiac applications: a review by the Society for Pediatric Radiology (SPR) and the International Contrast Ultrasound Society (ICUS)Pediatric Radiology, 2013
- Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver – Update 2012Japanese Journal of Clinical Oncology, 2012
- Application of a second-generation US contrast agent in infants and children—a European questionnaire-based surveyPediatric Radiology, 2012
- Anaphylactic shock due to SonoVueAnnals of Allergy, Asthma & Immunology, 2012
- Contrast-enhanced sonography of malignant pediatric abdominal and pelvic solid tumors: preliminary safety and feasibility dataPediatric Radiology, 2012
- Intravenous Application of Second-Generation Ultrasound Contrast Agents in Children: A Review of the LiteratureUltraschall in der Medizin - European Journal of Ultrasound, 2011
- Ultrasound contrast agents: An overviewEuropean Journal of Radiology, 2006
- The safety of Sonovue® in abdominal applications: Retrospective analysis of 23188 investigationsJapanese Journal of Clinical Oncology, 2006
- Complement activation-related pseudoallergy: A new class of drug-induced acute immune toxicityToxicology, 2005
- Safety and Efficacy of Intravenous Contrast Imaging in Pediatric EchocardiographyPediatric Cardiology, 2004